Immunotherapeutic and Targeted Approaches to Mesothelioma Treatment
Immunotherapeutic and targeted approaches might make mesothelioma more responsive to chemotherapy. Malignant pleural mesothelioma is an aggressive disease. Asbestos exposure…
Bevacizumab: An Immune Therapy in Mesothelioma Treatment
Bevacizumab, an immune therapy, enhances the immune system to target cancer cells. Historically, chemotherapy drugs were considered the standard treatment.…
Cells Talking in the Tumor Microenvironment: Cracking the Code
The tumor microenvironment and stroma cells affect the progression and treatment of malignant pleural mesothelioma. A new study shows how…
Hope for Mesothelioma? Parasite Triggers Tumor Regression in the Lab
A parasite found in cat feces triggered tumor regression in recent animal studies in China. It is a hopeful sign…
Celiac Disease May Be a Little-Known Complication of Mesothelioma Immunotherapy
A new French case report shines a spotlight on a little-known potential complication of mesothelioma immunotherapy: celiac disease. Celiac disease…
“Remodeling” Mesothelioma Cells May Improve Responsiveness to Immunotherapy
Italian researchers are experimenting with the idea of remodeling mesothelioma cells from the inside out to improve their responsiveness to…
Immunotherapy and Chemotherapy Shrink Peritoneal Mesothelioma Tumors: New Case Reports
Two new case reports appear to support the idea that immunotherapy and chemotherapy can work together to fight peritoneal mesothelioma. …
Relapsed Mesothelioma Patients Live Longer on Opdivo in Phase 3 Trial
A multi-center British study suggests that the cancer drug Opdivo (nivolumab) may be a solid second-line treatment option for relapsed…
Yervoy and Opdivo for Mesothelioma: Three Year Results Still Look Good
Three years after the last patients enrolled in the clinical trial of Yervoy and Opdivo for mesothelioma, survival results still…
Immune Checkpoint Inhibitor Safe Both Before and After Mesothelioma Surgery
A report presented to an international gathering of lung cancer doctors shows an immune checkpoint inhibitor can make pre-surgery chemotherapy…